By Professor Ric Day

Journal articles

Ferdiana A; Mashuri YA; Wulandari LPL; Rahayu ID; Hasanah M; Ayuningsih Z; Batura N; Khan M; Liverani M; Guy R; Schierhout G; Kaldor J; Law M; Day R; Jan S; Wibawa T; Probandari A; Yeung S; Wiseman V, 2024, 'The impact of a multi-faceted intervention on non-prescription dispensing of antibiotics by urban community pharmacies in Indonesia: a mixed methods evaluation', BMJ Global Health, 9, http://dx.doi.org/10.1136/bmjgh-2024-015620

Shen I; Stojanova J; Yeo M; Olsen N; Lockart I; Wang M; Roggeveld J; Heerspink HJL; Greenfield JR; Day R; Danta M, 2024, 'A potential novel treatment for cirrhosis-related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease', British Journal of Clinical Pharmacology, 90, pp. 2529 - 2538, http://dx.doi.org/10.1111/bcp.16139

Carland JE; Carland DJ; Brett J; Stocker SL; Roberts DM; Day RO; Laba TL, 2024, 'Economic evaluations of therapeutic drug monitoring interventions in acute hospital-based settings: A systematic review', British Journal of Clinical Pharmacology, 90, pp. 2038 - 2066, http://dx.doi.org/10.1111/bcp.16164

Schulz M; Day RO; Coleshill MJ; Briggs NE; Aung E, 2024, 'Psychometric evaluation of the Adherence to Refills and Medications Scale (ARMS) in Australians living with gout', Clinical Rheumatology, 43, pp. 2943 - 2954, http://dx.doi.org/10.1007/s10067-024-07050-y

Wabe N; Huang G; Silva SM; Nguyen AD; Seaman K; Raban MZ; Gates P; Day R; Close JCT; Lord SR; Westbrook JI, 2024, 'A Longitudinal Study of the Use and Effects of Fall-Risk-Increasing Drugs in Residential Aged Care', Journal of the American Medical Directors Association, 25, http://dx.doi.org/10.1016/j.jamda.2024.105074

Kirubakaran R; Singh RM; Carland JE; Day RO; Stocker SL, 2024, 'Evaluation of Published Population Pharmacokinetic Models to Inform Tacrolimus Therapy in Adult Lung Transplant Recipients', Therapeutic Drug Monitoring, 46, pp. 434 - 445, http://dx.doi.org/10.1097/FTD.0000000000001210

Mumford V; Raban MZ; Li L; Fitzpatrick E; Woods A; Merchant A; Badgery-Parker T; Gates P; Baysari M; Day RO; Ambler G; Dalla-Pozza L; Gazarian M; Gardo A; Barclay P; White L; Westbrook JI, 2024, 'Developing a process to measure actual harm from medication errors in paediatric inpatients: From design to implementation', British Journal of Clinical Pharmacology, 90, pp. 1615 - 1626, http://dx.doi.org/10.1111/bcp.16052

de Oliveira Costa J; Lin J; Milder TY; Greenfield JR; Day RO; Stocker SL; Neuen BL; Havard A; Pearson SA; Falster MO, 2024, 'Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia', Diabetes, Obesity and Metabolism, 26, pp. 2787 - 2795, http://dx.doi.org/10.1111/dom.15597

Selvadurai D; Coleshill MJ; Day RO; Briggs NE; Schulz M; Reath J; Aung E, 2024, 'Patient factors and health outcomes associated with illness perceptions in people with gout', Rheumatology (United Kingdom), 63, pp. 1927 - 1937, http://dx.doi.org/10.1093/rheumatology/kead501

Michael TJF; Wright DFB; Chan JS; Coleshill MJ; Aslani P; Hughes DA; Day RO; Stocker SL, 2024, 'Patient-Led Urate Self-Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study', ACR Open Rheumatology, 6, pp. 403 - 411, http://dx.doi.org/10.1002/acr2.11666

Carland JE; Stojanova J; Lau C; Day RO; Marriott DJE, 2024, 'Crying Over Stark Differences: Resource Disparity and Therapeutic Drug Monitoring', Therapeutic Drug Monitoring, 46, pp. 415 - 416, http://dx.doi.org/10.1097/FTD.0000000000001185

Li L; Baker J; Quirk R; Deidun D; Moran M; Salem AA; Aryal N; Van Dort BA; Zheng WY; Hargreaves A; Doherty P; Hilmer SN; Day RO; Westbrook JI; Baysari MT, 2024, 'Drug–Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation', Drug Safety, 47, pp. 557 - 569, http://dx.doi.org/10.1007/s40264-024-01412-w

Jones CMP; Day RO; Koes BW; Latimer J; Maher CG; McLachlan AJ; Billot L; Shan S; Lin CWC, 2024, 'Opioids for back and neck pain: the OPAL trial – Authors' reply', The Lancet, 403, pp. 2379 - 2380, http://dx.doi.org/10.1016/S0140-6736(24)00487-2

Michael TJF; Chan JS; Hughes S; Wright DFB; Coleshill MJ; Hughes DA; Day RO; Aslani P; Stocker SL, 2024, 'The experiences and perspectives of people with gout on urate self-monitoring', Health Expectations, 27, http://dx.doi.org/10.1111/hex.14071

Schulz M; Coleshill MJ; Day RO; Wright DFB; Brett J; Briggs NE; Aung E, 2024, 'Estimation of adherence to urate-lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient-reported dosing', British Journal of Clinical Pharmacology, 90, pp. 1322 - 1332, http://dx.doi.org/10.1111/bcp.16016

Gilanyi YL; Shah B; Cashin AG; Gibbs MT; Bellamy J; Day R; McAuley JH; Jones MD; McAuley J; Bellamy J; Gibbs M, 2024, 'Barriers and enablers to exercise adherence in people with nonspecific chronic low back pain: a systematic review of qualitative evidence.', Pain, 165, pp. 2200 - 2214, http://dx.doi.org/10.1097/j.pain.0000000000003234

Milder TY; Stocker SL; Baysari MT; Day RO; Greenfield JR, 2024, '‘We are somehow fixated on this being a diabetes drug’: a qualitative study exploring the views of cardiologists and nephrologists about sodium-glucose cotransporter 2 inhibitor initiation', Internal Medicine Journal, 54, pp. 559 - 567, http://dx.doi.org/10.1111/imj.16203

Baysari MT; Van Dort BA; Stanceski K; Hargreaves A; Zheng WY; Moran M; Day RO; Li L; Westbrook J; Hilmer SN, 2024, 'Qualitative study of challenges with recruitment of hospitals into a cluster controlled trial of clinical decision support in Australia', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-080610

Milder TY; Lin J; Pearson SA; de Oliveira Costa J; Neuen BL; Pollock C; Jun M; Greenfield JR; Day RO; Stocker SL; Brieger D; Falster MO, 2024, 'Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?', Diabetes, Obesity and Metabolism, http://dx.doi.org/10.1111/dom.16061

Chui B; Day R; Umashankar E; Abdel Shaheed C; Keogh A; Girgis L; Penglase R, 2024, 'Meta-analysis and systematic review of gout prevalence in the heart/lung transplantation population', Frontiers in Transplantation, 3, http://dx.doi.org/10.3389/frtra.2024.1356058

Jones CMP; Langford A; Maher CG; Abdel Shaheed C; Day R; Lin CWC, 2024, 'Opioids for Acute Musculoskeletal Pain: A Systematic Review with Meta-Analysis', Drugs, http://dx.doi.org/10.1007/s40265-024-01999-5

Milder TY; Lin J; Pearson SA; Greenfield JR; Day RO; Stocker SL; Neuen BL; Falster MO; de Oliveira Costa J, 2024, 'Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018–2022', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.16231

Jones CMP; Lin CWC; Day RO; Koes BW; Latimer J; Maher CG; McLachlan A; Billot L, 2023, 'Correction: OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain—a statistical analysis plan (Trials, (2022), 23, 1, (212), 10.1186/s13063-022-06028-y)', Trials, 24, http://dx.doi.org/10.1186/s13063-023-07525-4

Day RO, 2023, 'Ongoing challenges of off-label prescribing', Australian Prescriber, 46, pp. 86 - 89, http://dx.doi.org/10.18773/austprescr.2023.022

Milder TY; Milder DA; Greenfield JR; Day RO, 2023, 'Sodium-Glucose Cotransporter 2 Inhibitor-Associated “Ketoacidosis” Versus “Diabetic Ketoacidosis”: The Importance of Accurate Terminology', Drug Safety, 46, pp. 1303 - 1305, http://dx.doi.org/10.1007/s40264-023-01358-5

Ferreira GE; Zadro J; Jones C; Ayre J; Lin C; Richards B; Needs C; Shaheed CA; McLachlan A; Day RO; Maher C, 2023, 'General practitioners’ decision-making process to prescribe pain medicines for low back pain: a qualitative study', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2023-074380

Yang JJ; Brett J; Sordo A; Reuter SE; Stocker SL; Day RO; Roberts DM; Carland JE, 2023, 'The Influence of a Therapeutic Drug Monitoring Service on Vancomycin-Associated Nephrotoxicity', Journal of Clinical Pharmacology, 64, pp. 19 - 29, http://dx.doi.org/10.1002/jcph.2363

Chin PKL; Charles K; Murnion B; McGuire TM; Hilmer SN; Martin J; Reith D; Joyce D; Lucas C; Holford N; Day R; Schneider J; Doogue M; Han CH; Herd S; Harrison C; O'Mara D, 2023, 'Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand', British Journal of Clinical Pharmacology, 89, pp. 3105 - 3115, http://dx.doi.org/10.1111/bcp.15814

Stefani M; Musgrave K; Sevastos J; Penny M; Day RO; Roberts DM, 2023, 'Optimizing the dosing of vancomycin in patients receiving intermittent haemodialysis with low-flux filters, and the potential impact of dosing software', Nephrology, 28, pp. 534 - 539, http://dx.doi.org/10.1111/nep.14198

Li L; Baker J; Rathnayake K; Kotwal S; Westbrook JI; Day R; Endre Z, 2023, 'Medication use and hospital-acquired acute kidney injury: an electronic health record-based study', Internal Medicine Journal, 53, pp. 1625 - 1633, http://dx.doi.org/10.1111/imj.15938

Lin J; Pearson SA; Greenfield JR; Park KH; Havard A; Brieger D; Day RO; Falster MO; de Oliveira Costa J, 2023, 'Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)', European Journal of Clinical Pharmacology, 79, pp. 1239 - 1248, http://dx.doi.org/10.1007/s00228-023-03539-8

Chowdhury G; Carland JE; Kumar S; Olsen N; Graham G; Kumarasinghe G; Hayward CS; Greenfield JR; Macdonald P; Day RO; Stocker SL, 2023, 'The safe use of metformin in heart failure patients both with and without T2DM: A cross-sectional and longitudinal study', British Journal of Clinical Pharmacology, 89, pp. 2603 - 2613, http://dx.doi.org/10.1111/bcp.15737

Jones CMP; Day RO; Koes BW; Latimer J; Maher CG; McLachlan AJ; Billot L; Shan S; Lin CWC; McLachlan H; Webb M; Hamilton M; Ahedi H; Barber A; Mak W; Mathieson S; Petrova V; Bompoint S; Murnion B; Buckley N; Demirkol A; Wrigley P; Needs C; Brooks L; Cantori S; Preisz P; Aitken J; Allan S; Burke M; Cameron G; Cepeda FJV; Davis C; Dullur J; Emmanuel J; Errey C; Fieuw-Makaroff S; Gaudry A; Genua L; Longhurst I; McCroary K; Merhi D; Nguyen T; Obayd ZR; Penm M; Pobbathi S; Poh WS; Schnitzler P; Shahnaz S; Tan V; Tang D; Tan B; Thu WK; Triantopolous T; Venkatesan R; Wong WCF; Yang SC, 2023, 'Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial', The Lancet, 402, pp. 304 - 312, http://dx.doi.org/10.1016/S0140-6736(23)00404-X

Brett J; Bahceci D; Lipworth W; Liknaitzky P; Day RO; Rodgers A, 2023, 'Can old drugs learn new tricks? Achieving registration and public subsidy listing for off-patent medicines with novel therapeutic applications', Internal Medicine Journal, 53, pp. 1284 - 1287, http://dx.doi.org/10.1111/imj.16159

Spragg JCJ; Michael TJF; Aslani P; Coleshill MJ; Chan JS; Day RO; Stocker SL, 2023, 'Optimizing adherence to allopurinol for gout: patients' perspectives', British Journal of Clinical Pharmacology, 89, pp. 1978 - 1991, http://dx.doi.org/10.1111/bcp.15657

Stojanova J; Day RO; Suthers G, 2023, 'Avoiding severe drug hypersensitivity reactions: a case for HLA genotyping for at-risk patients', Medical Journal of Australia, 218, pp. 441 - 444, http://dx.doi.org/10.5694/mja2.51937

Carland JE; Stacy AE; Schaffer AL; Day RO; Brett J; Reuter SE; Stocker SL, 2023, 'Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycin', British Journal of Clinical Pharmacology, 89, pp. 1896 - 1902, http://dx.doi.org/10.1111/bcp.15668

Kirubakaran R; Uster DW; Hennig S; Carland JE; Day RO; Wicha SG; Stocker SL, 2023, 'Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients', British Journal of Clinical Pharmacology, 89, pp. 1162 - 1175, http://dx.doi.org/10.1111/bcp.15566

Wise S; Smith E; Carlos L; Coleshill M; Day RO; Melocco T; Carland JE, 2023, 'Who is asking? Requests for antimicrobial prescribing advice received by hospital pharmacists', Journal of Pharmacy Practice and Research, 53, pp. 39 - 43, http://dx.doi.org/10.1002/jppr.1841

Wewege MA; Bagg MK; Jones MD; Ferraro MC; Cashin AG; Rizzo RRN; Leake HB; Hagstrom AD; Sharma S; McLachlan AJ; Maher CG; Day R; Wand BM; O'Connell NE; Nikolakopolou A; Schabrun S; Gustin SM; McAuley JH; Hagstrom M, 2023, 'Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis', BMJ, 380, pp. e072962, http://dx.doi.org/10.1136/bmj-2022-072962

Ferreira GE; Abdel-Shaheed C; Underwood M; Finnerup NB; Day RO; McLachlan A; Eldabe S; Zadro JR; Maher CG, 2023, 'Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews', BMJ, http://dx.doi.org/10.1136/bmj-2022-072415

Sullivan JK; Fahey PP; Agho KE; Hurley SP; Feng Z; Day RO; Lim D, 2023, 'Valproic acid as a radio-sensitizer in glioma: A systematic review and meta-analysis.', Neurooncol Pract, 10, pp. 13 - 23, http://dx.doi.org/10.1093/nop/npac078

Chaudhri K; Kearney M; Di Tanna GL; Gnanenthiran SR; Day RO; Rodgers A; Atkins ER, 2022, 'Does splitting a tablet obtain an accurate dose? A systematic review and meta- analysis', Journal of Pharmacy Practice and Research, 52, pp. 411 - 421, http://dx.doi.org/10.1002/jppr.1843

Jones CMP; Lin CWC; Day RO; Koes BW; Latimer J; Maher CG; McLachlan A; Billot L, 2022, 'OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain—a statistical analysis plan', Trials, 23, http://dx.doi.org/10.1186/s13063-022-06028-y

Kamel B; Abuhelwa AY; Foster D; Duong JK; Graham GG; Williams KM; Pile KD; Day RO, 2022, 'Population pharmacokinetic modelling of febuxostat in healthy subjects and people with gout', British Journal of Clinical Pharmacology, 88, pp. 5359 - 5368, http://dx.doi.org/10.1111/bcp.15462

Westbrook JI; Li L; Raban MZ; Mumford V; Badgery-Parker T; Gates P; Fitzpatrick E; Merchant A; Woods A; Baysari M; McCullagh C; Day R; Gazarian M; Dickinson M; Seaman K; Dalla-Pozza L; Ambler G; Barclay P; Gardo A; O’Brien T; Barbaric D; White L; O'Brien T, 2022, 'Short- and long-term effects of an electronic medication management system on paediatric prescribing errors', npj Digital Medicine, 5, pp. 179, http://dx.doi.org/10.1038/s41746-022-00739-x

Yager RC; Taylor N; Stocker SL; Day RO; Baysari MT; Carland JE, 2022, 'Would they accept it? An interview study to identify barriers and facilitators to user acceptance of a prescribing advice service', BMC Health Services Research, 22, http://dx.doi.org/10.1186/s12913-022-07927-1

Radovanovic M; Day RO; Jones GDR; Galettis P; Norris RLG, 2022, 'LC–MS/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring', Journal of Mass Spectrometry and Advances in the Clinical Lab, 26, pp. 48 - 59, http://dx.doi.org/10.1016/j.jmsacl.2022.11.001

Coleshill MJ; Day RO; Tam K; Kouhkamari M; Caillet V; Aung E; Kannangara DRW; Cronin P; Rodgers A; Stocker SL, 2022, 'Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions', British Journal of Clinical Pharmacology, 88, pp. 4894 - 4901, http://dx.doi.org/10.1111/bcp.15435

Tiwary M; Milder TY; Stocker SL; Day RO; Greenfield JR, 2022, 'Sodium-glucose co-transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restriction', Internal Medicine Journal, 52, pp. 1666 - 1676, http://dx.doi.org/10.1111/imj.15727

Back to profile page